Angel Biotechnology Ltd to Sell Cramlington Facility, Concentrate Output at Pentlands

LONDON (Thomson Financial) - Angel Biotechnology Holdings PLC said, following the increased cost burden at its Cramlington facility near Newcastle, it has decided to close and sell it and concentrate production at its Pentlands, Edinburgh, facility.

MORE ON THIS TOPIC